Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| X4 Pharmaceuticals, Inc | 2,329,154 | reported | 29 Oct 2025 | tx 5+4,844,315 |
| Innovive Pharmaceuticals, Inc. | 37,500 | reported | 10 Jul 2007 | tx 9+268,193−17,120 |
| SUNESIS PHARMACEUTICALS INC | 31,754 | reported | 27 Feb 2015 | tx 8+1,031,693−10,856 |
| CELL THERAPEUTICS INC | 0 | reported | 26 Jun 2023 | tx 86+10,019,386−10,093,639 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Oct 2025 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 2,329,154 | 0.00 USD | deriv |
| 23 Oct 2025 | PURCHASE | X4 Pharmaceuticals, Inc | 86,206 | 2.90 USD | first after silence |
| 14 Aug 2025 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 289,881 | 0.00 USD | |
| 12 Aug 2025 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 1,609,873 | 0.00 USD | deriv |
| 14 Aug 2025 | GRANT_AWARD | X4 Pharmaceuticals, Inc | 529,201 | 0.00 USD | deriv |
| 26 Jun 2023 | TENDER | CELL THERAPEUTICS INC | 31,470 | 9.10 USD | |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 900,000 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 1,115,000 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 800,000 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 2,320,000 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 470,054 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 600,000 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 475,000 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 1,200,000 | — | deriv |
| 26 Jun 2023 | OTHER | CELL THERAPEUTICS INC | 450,000 | — | deriv |
| 14 Mar 2023 | GRANT_AWARD | CELL THERAPEUTICS INC | 900,000 | 0.00 USD | deriv |
| 24 Jan 2023 | EXERCISE | CELL THERAPEUTICS INC | 83,200 | 0.84 USD | |
| 24 Jan 2023 | SALE | CELL THERAPEUTICS INC | 2,117 | 6.01 USD | |
| 24 Jan 2023 | EXERCISE | CELL THERAPEUTICS INC | 2,117 | 0.84 USD | |
| 24 Jan 2023 | SALE | CELL THERAPEUTICS INC | 83,200 | 6.00 USD | |
| 24 Jan 2023 | EXERCISE | CELL THERAPEUTICS INC | 83,200 | 0.00 USD | deriv |
| 24 Jan 2023 | EXERCISE | CELL THERAPEUTICS INC | 2,117 | 0.00 USD | deriv |
| 29 Dec 2022 | SALE | CELL THERAPEUTICS INC | 13,800 | 6.00 USD | |
| 30 Dec 2022 | GRANT_AWARD | CELL THERAPEUTICS INC | 1,579 | 5.11 USD | |
| 29 Dec 2022 | EXERCISE | CELL THERAPEUTICS INC | 13,800 | 0.84 USD |
2 purchases reported after at least 12 months of silence — most recent on 23 Oct 2025.